Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Shawn Kwatra

Showing results (1-10 of 9) with videos related to

Pageof 1
Sort By:
Frontiers in Medicine|March 12, 2024
Editorial: Itch treatmentsMartin Steinhoff, Shawn Kwatra, Laurent Misery
Dermatology Online Journal|December 11, 2012
Autosomal dominant transmission of nevus sebaceous of JadassohnCameron West, Swetha Narahari, Shawn Kwatra, et al.
Archives of Dermatological Research|April 24, 2021
Lifestyle modifications associated with symptom improvement in hidradenitis suppurativa patientsPaul C Macklis, Kelly Tyler, Jessica Kaffenberger, et al.
Clinical and Experimental Dermatology|July 25, 2025
Cigarette smoking, obesity, and alcohol use among patients with prurigo nodularisViviane Liao, Shahin Shahsavari, Yagiz Matthew Akiska, et al.
The Journal of Clinical and Aesthetic Dermatology|March 13, 2025
Investigating Efficacy of Atopic Dermatitis Systemic Therapeutics After Discontinuation Part I: BiologicsNaiem T Issa, Rama Abdin, Kabir Al-Tariq, et al.
The British Journal of Dermatology|August 12, 2025
Epigenetic Profiling Reveals Neuroimmune and Fibrotic Pathway Dysregulation in Prurigo NodularisShahin Shahsavari, Kavita Vats, Jonathan Wang, et al.
Research Square|May 3, 2023
ERK Hyperactivation Serves as a Unified Mechanism of Escape in Intrinsic and Acquired CDK4/6 Inhibitor Resistance in Acral Lentiginous MelanomaVito Rebecca, Kasturee Jagirdar, Marie Portuallo, et al.
Oncogene|December 8, 2023
ERK hyperactivation serves as a unified mechanism of escape in intrinsic and acquired CDK4/6 inhibitor resistance in acral lentiginous melanomaKasturee Jagirdar, Marie E Portuallo, Meihan Wei, et al.
Journal for Immunotherapy of Cancer|April 10, 2024
Defining D-irAEs: consensus-based disease definitions for the diagnosis of dermatologic adverse events from immune checkpoint inhibitor therapySteven T Chen, Yevgeniy R Semenov, Allireza Alloo, et al.
Pageof 1

Showing results (1-10 of 9) with videos related to

Sort By:
Pageof 1
Frontiers in Medicine|March 12, 2024
Editorial: Itch treatmentsMartin Steinhoff, Shawn Kwatra, Laurent Misery
Dermatology Online Journal|December 11, 2012
Autosomal dominant transmission of nevus sebaceous of JadassohnCameron West, Swetha Narahari, Shawn Kwatra, et al.
Archives of Dermatological Research|April 24, 2021
Lifestyle modifications associated with symptom improvement in hidradenitis suppurativa patientsPaul C Macklis, Kelly Tyler, Jessica Kaffenberger, et al.
Clinical and Experimental Dermatology|July 25, 2025
Cigarette smoking, obesity, and alcohol use among patients with prurigo nodularisViviane Liao, Shahin Shahsavari, Yagiz Matthew Akiska, et al.
The Journal of Clinical and Aesthetic Dermatology|March 13, 2025
Investigating Efficacy of Atopic Dermatitis Systemic Therapeutics After Discontinuation Part I: BiologicsNaiem T Issa, Rama Abdin, Kabir Al-Tariq, et al.
The British Journal of Dermatology|August 12, 2025
Epigenetic Profiling Reveals Neuroimmune and Fibrotic Pathway Dysregulation in Prurigo NodularisShahin Shahsavari, Kavita Vats, Jonathan Wang, et al.
Research Square|May 3, 2023
ERK Hyperactivation Serves as a Unified Mechanism of Escape in Intrinsic and Acquired CDK4/6 Inhibitor Resistance in Acral Lentiginous MelanomaVito Rebecca, Kasturee Jagirdar, Marie Portuallo, et al.
Oncogene|December 8, 2023
ERK hyperactivation serves as a unified mechanism of escape in intrinsic and acquired CDK4/6 inhibitor resistance in acral lentiginous melanomaKasturee Jagirdar, Marie E Portuallo, Meihan Wei, et al.
Journal for Immunotherapy of Cancer|April 10, 2024
Defining D-irAEs: consensus-based disease definitions for the diagnosis of dermatologic adverse events from immune checkpoint inhibitor therapySteven T Chen, Yevgeniy R Semenov, Allireza Alloo, et al.
Pageof 1